Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
2010 5
2011 2
2012 7
2013 5
2014 2
2015 3
2016 4
2017 1
2018 3
2019 5
2020 5
2021 9
2022 14
2023 13
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO).
Francolini G, Allegra AG, Detti B, Di Cataldo V, Caini S, Bruni A, Ingrosso G, D'Angelillo RM, Alitto AR, Augugliaro M, Triggiani L, Parisi S, Facchini G, Banini M, Simontacchi G, Desideri I, Meattini I, Valicenti RK, Livi L; ARTO Working Group members. Francolini G, et al. Among authors: di cataldo v. J Clin Oncol. 2023 Dec 20;41(36):5561-5568. doi: 10.1200/JCO.23.00985. Epub 2023 Sep 21. J Clin Oncol. 2023. PMID: 37733977 Clinical Trial.
In Reply to Guler and Onal.
Francolini G, Di Cataldo V, Detti B, Livi L. Francolini G, et al. Among authors: di cataldo v. Clin Oncol (R Coll Radiol). 2022 Jan;34(1):e84-e85. doi: 10.1016/j.clon.2021.11.007. Epub 2021 Nov 26. Clin Oncol (R Coll Radiol). 2022. PMID: 34844864 No abstract available.
Role of chemotherapy in nasopharyngeal carcinoma.
Paiar F, Di Cataldo V, Zei G, Pasquetti EM, Cecchini S, Meattini I, Mangoni M, Agresti B, Iermano C, Bonomo P, Biti G. Paiar F, et al. Among authors: di cataldo v. Oncol Rev. 2012 Jan 5;6(1):e1. doi: 10.4081/oncol.2012.e1. eCollection 2012 Mar 5. Oncol Rev. 2012. PMID: 25992199 Free PMC article. Review.
Choline PET/CT in recurrent prostate cancer.
Detti B, Carnevale MG, Lucidi S, Burchini L, Caini S, Orsatti C, Bertini N, Roghi M, di Cataldo V, Fondelli S, Ingrosso G, Francolini G, Scartoni D, Sardaro A, Pisani A, Scoccianti S, Aristei C, Livi L. Detti B, et al. Among authors: di cataldo v. Front Oncol. 2023 Mar 21;13:1079808. doi: 10.3389/fonc.2023.1079808. eCollection 2023. Front Oncol. 2023. PMID: 37025599 Free PMC article.
Stem cell tracking: toward clinical application in oncology?
Mangoni M, Livi L, Biti G, Di Cataldo V, Capaccioli N, Castier Y, Loriot Y, Mordant P, Deutsch E. Mangoni M, et al. Among authors: di cataldo v. Tumori. 2012 Sep-Oct;98(5):535-42. doi: 10.1177/030089161209800501. Tumori. 2012. PMID: 23235746 Review.
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results.
Francolini G, Ganovelli M, Di Cataldo V, Detti B, Caini S, Loi M, Simontacchi G, Desideri I, Greto D, Valzano M, Serni S, Vaggelli L, Salvestrini V, Visani L, Becherini C, Olmetto E, Franzese C, Baldaccini D, Scorsetti M, Sollini M, Chiti A, Meattini I, Valicenti RK, Livi L. Francolini G, et al. Among authors: di cataldo v. Clin Exp Metastasis. 2023 Apr;40(2):197-201. doi: 10.1007/s10585-023-10204-y. Epub 2023 Apr 3. Clin Exp Metastasis. 2023. PMID: 37012498 Free PMC article.
Local treatment for relapsing glioblastoma: A decision-making tree for choosing between reirradiation and second surgery.
Scoccianti S, Perna M, Olmetto E, Delli Paoli C, Terziani F, Ciccone LP, Detti B, Greto D, Simontacchi G, Grassi R, Scoccimarro E, Bonomo P, Mangoni M, Desideri I, Di Cataldo V, Vernaleone M, Casati M, Pallotta S, Livi L. Scoccianti S, et al. Among authors: di cataldo v. Crit Rev Oncol Hematol. 2021 Jan;157:103184. doi: 10.1016/j.critrevonc.2020.103184. Epub 2020 Nov 28. Crit Rev Oncol Hematol. 2021. PMID: 33307416 Review.
PERSIAN trial (NCT05717660): an ongoing randomized trial testing androgen deprivation therapy, apalutamide and stereotactic body radiotherapy. An alternative "triplet" for oligometastatic hormone sensitive prostate cancer patients.
Francolini G, Porreca A, Facchini G, Santini D, Bruni A, Simoni N, Trovò M, Osti MF, Fornarini G, Sisani M, Di Cataldo V, Detti B, Garlatti P, Bertini N, Serni S, Minervini A, Livi L. Francolini G, et al. Among authors: di cataldo v. Med Oncol. 2023 Dec 29;41(1):39. doi: 10.1007/s12032-023-02268-3. Med Oncol. 2023. PMID: 38157111 Clinical Trial.
Toxicity after moderately hypofractionated versus conventionally fractionated prostate radiotherapy: A systematic review and meta-analysis of the current literature.
Francolini G, Detti B, Becherini C, Caini S, Ingrosso G, Di Cataldo V, Stocchi G, Salvestrini V, Lancia A, Scartoni D, Giacomelli I, Sardaro A, Carbonara R, Borghesi S, Aristei C, Livi L. Francolini G, et al. Among authors: di cataldo v. Crit Rev Oncol Hematol. 2021 Sep;165:103432. doi: 10.1016/j.critrevonc.2021.103432. Epub 2021 Aug 3. Crit Rev Oncol Hematol. 2021. PMID: 34352361 Review.
71 results